← All compounds
Compound Deep-Dive
Tier 4: PeptideA potent experimental weight-loss peptide that shows best results when combined with a GLP-1 agonist.
Cagrilintide
AM833
Potent weight loss, still experimental.
Hype Risk
8/10
Noticeability
9/10
Evidence Tier
Moderate
Cost / Month
~$350
Experimental drug
What it's actually good for
Energy: neutralFocus: neutralSleep: neutralRecovery: neutralMood: neutralImmunity: neutral
How it works
Cagrilintide is a long-acting amylin analogue that promotes weight loss by increasing satiety and slowing gastric emptying. Clinical trials demonstrate significant weight reduction, particularly when used in combination with GLP-1 receptor agonists.
Acts as a potent agonist of amylin receptors, mimicking the natural satiety hormone to reduce food intake and delay stomach emptying.
Safety
- Gastrointestinal distress (nausea, vomiting) is the most frequent side effect.
- Requires subcutaneous injection; proper sterile technique is essential.
- Not FDA-approved; currently in Phase 3 clinical trials.
The full StackRoast report adds
- The exact dose, timing, and effective range to actually run it at
- Where people go wrong with it — the dose-creep and timing traps
- What Cagrilintide clashes with or duplicates in your stack
Community Reality Check
Distilled from 300 threads
Community Reality Check
Distilled from 300 threadsConfidence: medium
What users report
- Appetite suppression
- Weight loss synergy
- Reduced food noise
The catch
- Nausea
- Cost
- Injection anxiety
Side effects reported
- Nausea
- Vomiting
- Diarrhea
- Fatigue
https://www.reddit.com/r/Peptideshttps://www.reddit.com/r/CagriSema
The Receipts
6 sources— studies, videos & links
The Receipts
6 sources— studies, videos & linksTaking Cagrilintide in a stack? Find out if the combination actually makes sense.
Roast My Stack →